CA2225628A1 - Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors - Google Patents

Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors

Info

Publication number
CA2225628A1
CA2225628A1 CA002225628A CA2225628A CA2225628A1 CA 2225628 A1 CA2225628 A1 CA 2225628A1 CA 002225628 A CA002225628 A CA 002225628A CA 2225628 A CA2225628 A CA 2225628A CA 2225628 A1 CA2225628 A1 CA 2225628A1
Authority
CA
Canada
Prior art keywords
proton pump
oral pharmaceutical
reversible proton
pharmaceutical compositions
delayed release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002225628A
Other languages
French (fr)
Other versions
CA2225628C (en
Inventor
Rango Dietrich
George Sachs
Stefan Postius
Hartmut Ney
Jorg Senn-Bilfinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik Gmbh
Rango Dietrich
George Sachs
Stefan Postius
Hartmut Ney
Jorg Senn-Bilfinger
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/498,391 external-priority patent/US6132768A/en
Application filed by Byk Gulden Lomberg Chemische Fabrik Gmbh, Rango Dietrich, George Sachs, Stefan Postius, Hartmut Ney, Jorg Senn-Bilfinger, Altana Pharma Ag filed Critical Byk Gulden Lomberg Chemische Fabrik Gmbh
Publication of CA2225628A1 publication Critical patent/CA2225628A1/en
Application granted granted Critical
Publication of CA2225628C publication Critical patent/CA2225628C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Abstract

An oral pharmaceutical composition of a reversible proton pump inhibitor in pellet or tablet form, wherein the reversible proton pump inhibitor is at least partly in slow-release form, is distinguished, on combined administration with an antimicrobially-active ingredient, by an enhanced action of rapid onset against disorders caused by Helicobacter.
CA002225628A 1995-07-05 1996-07-02 Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors Expired - Fee Related CA2225628C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/498,391 1995-07-05
US08/498,391 US6132768A (en) 1995-07-05 1995-07-05 Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
PCT/EP1996/002893 WO1997002021A1 (en) 1995-07-05 1996-07-02 Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors

Publications (2)

Publication Number Publication Date
CA2225628A1 true CA2225628A1 (en) 1997-01-23
CA2225628C CA2225628C (en) 2007-01-02

Family

ID=37603476

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002225628A Expired - Fee Related CA2225628C (en) 1995-07-05 1996-07-02 Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors

Country Status (1)

Country Link
CA (1) CA2225628C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9607182B1 (en) 2016-02-02 2017-03-28 International Business Machines Corporation Universal emergency power-off switch security device

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9607182B1 (en) 2016-02-02 2017-03-28 International Business Machines Corporation Universal emergency power-off switch security device
US9665741B1 (en) 2016-02-02 2017-05-30 International Business Machines Corporation Universal emergency power-off switch security device

Also Published As

Publication number Publication date
CA2225628C (en) 2007-01-02

Similar Documents

Publication Publication Date Title
AU6517596A (en) Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors
DK1213015T3 (en) Oral pharmaceutical composition with delayed release of proton pump inhibitors
CA2199778A1 (en) Extended release formulation of venlafaxine
CA2315927A1 (en) Oral pharmaceutical pulsed release dosage form
PT1003486E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AN ACTIVE BASE-EFFECTS
IL109186A0 (en) Stable, ingestable and absorbable nadh and nadph therapeutic compositions
WO2001087330A3 (en) Compositions and methods for achieving immune suppression
UA27058C2 (en) Ibuprofen-containing pharmaceutical composition for the preparation of effervescent powders or tablets, pharmaceutical preparation on said and method of its preparing
NZ504460A (en) Sustained release formulations containing venlafaxine
WO2001043747A8 (en) Matrix tablet for prolonged release of trimetazidine after oral administration
AU2697100A (en) Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
CA2225628A1 (en) Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors
AU4929400A (en) Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof
WO2002053097A3 (en) Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
WO2001022917A8 (en) Effervescent compositions comprising nimesulide
AU3903701A (en) Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase
WO2004056353A3 (en) Device and method for delivering mmp inhibitors

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed